Research and Innovation Services Partner with us Our Technologies Dendritic Cell Immunomodulator Screening Assay
Dendritic Cell Immunomodulator Screening Assay
- Future Students
- Ò»±¾µÀGlobal Experience
- International Students
- Open Day
- How to apply
- Pathways to university
- Virtual Open Day
- Living on Campus
- Courses
- Publications
- Scholarships
- Parents and Partners
- Ò»±¾µÀHeroes Programs
- Aboriginal and Torres Strait Islander in Marine Science
- Elite Athletes
- Defence
- AI@Ò»±¾µÀ
- Current Students
- New students
- Ò»±¾µÀOrientation
- LearnÒ»±¾µÀ
- Placements
- CEE
- Unicare Centre and Unicampus Kids
- Graduation
- Off-Campus Students
- Ò»±¾µÀJob Ready
- Safety and Wellbeing
- Ò»±¾µÀPrizes
- Professional Experience Placement
- Employability Edge
- Art of Academic Writing
- Art of Academic Editing
- Careers and Employability
- Student Equity and Wellbeing
- Career Ready Plan
- Careers at Ò»±¾µÀ
- Ò»±¾µÀ
- JCU-CSIRO Partnership
- Alumni
- About Ò»±¾µÀ
- Reputation and Experience
- Chancellery
- Governance
- Celebrating 50 Years
- Academy
- Indigenous Engagement
- Education Division
- Graduate Research School
- Research and Teaching
- Research Division
-
Research and Innovation Services
- About Research and Innovation Services
- Partner with us
- Innovate with us
- Research Grants, Tenders and Funding
- Ethics and Research Integrity
- Research Contracts
- Discover our Research and Testing Facilities
- Ò»±¾µÀIdeas Lab
- Contact Research and Innovation Services
- FAQs and Fact Sheets
- GECO
- CASE
- College of Business, Law and Governance
- College of Healthcare Sciences
- College of Medicine and Dentistry
- College of Science and Engineering
- CPHMVS
- Anthropological Laboratory for Tropical Audiovisual Research (ALTAR)
- Anton Breinl Research Centre
- Agriculture Technology and Adoption Centre (AgTAC)
- Advanced Analytical Centre
- AMHHEC
- Aquaculture Solutions
- AusAsian Mental Health Research Group
- ARCSTA
- Area 61
- Lions Marine Research Trust
- Australian Tropical Herbarium
- Australian Quantum & Classical Transport Physics Group
- Boating and Diving
- Clinical Psychedelic Research Lab
- Centre for Tropical Biosecurity
- Centre for Tropical Bioinformatics and Molecular Biology
- CITBA
- CMT
- Centre for Disaster Solutions
- CSTFA
- Cyclone Testing Station
- The Centre for Disaster Studies
- Daintree Rainforest Observatory
- Ò»±¾µÀEduquarium
- Ò»±¾µÀTurtle Health Research
- Language and Culture Research Centre
- MARF
- Orpheus
- TESS
- Ò»±¾µÀIdeas Lab
- TARL
- eResearch
- Indigenous Education and Research Centre
- Estate
- Work Health and Safety
- Staff
- Discover Nature at Ò»±¾µÀ
- Cyber Security Hub
- Association of Australian University Secretaries
- Services and Resources Division
- Environmental Research Complex [ERC]
- Foundation for Australian Literary Studies
- Gender Equity Action and Research
- Give to Ò»±¾µÀ
- Indigenous Legal Needs Project
- Inherent Requirements
- IsoTropics Geochemistry Lab
- IT Services
- Ò»±¾µÀWebinars
- Ò»±¾µÀEvents
- Ò»±¾µÀMotorsports
- Ò»±¾µÀSport
- Library
- Mabo Decision: 30 years on
- Marine Geophysics Laboratory
- Office of the Vice Chancellor and President
- Outstanding Alumni
- Pharmacy Full Scope
- Planning for your future
- Policy
- PAHL
- Queensland Research Centre for Peripheral Vascular Disease
- Rapid Assessment Unit
- RDIM
- Researcher Development Portal
- Roderick Centre for Australian Literature and Creative Writing
- Contextual Science for Tropical Coastal Ecosystems
- State of the Tropics
- Strategic Procurement
- Student profiles
- SWIRLnet
- TREAD
- TropEco for Staff and Students
- TQ Maths Hub
- TUDLab
- VAVS Home
- WHOCC for Vector-borne & NTDs
- Media
- Copyright and Terms of Use
- Australian Institute of Tropical Health & Medicine
- Pay review
The screening platform identifies compounds that modulate dendritic cell function, for drug discovery
in cancer immunotherapy, autoimmunity, allergies, infectious diseases & transplant rejection. This is
a high content flow cytometry platform with up to 12 independent fluorescent readouts.
Background
Dendritic cells (DCs) are the key antigen presenting cells responsible for initiating adaptive immune response to pathogens and tumour antigens. In vitro assays based on DCs can be used to study drug & vaccine candidates. Existing technologies, based on DCs matured from blood precursors, miss ~half of the DC’s phenotypic repertoire because matured DCs are committed to an activated state.
The Doolan Lab in Ò»±¾µÀhas developed a screening platform based on resting-state DCs, with the novel capability of detecting compounds which up-regulate or down-regulate DC-mediated antigen presentation and co-stimulation.
Test compounds are incubated with dendritic cells in 96 well plate format and assayed with high- throughput, multi-parameter flow cytometry. Up to 12 independent readouts provide a comprehensive profile of DC function including antigen presentation (MHC class I and II expression, peptide-MHC-I complexes), co-stimulation signalling (OX40L, CD80, CD86, CD70, CD40, CD44), checkpoint signalling (PD-L1, PD-L2), migratory potential (chemokine receptors CCR5 and CCR7) and phagocytosis (bead uptake). Specific readouts can be custom-tailored to individual screening applications.
Some examples of results are as follows:
- Cholera toxin is a well known experimental vaccine adjuvant and induced strong up-regulation of expression of all DC activation markers, including co-stimulation signals, MHC molecules and cytokine receptors (Figure 1).
- Curcumin, a known co-stimulation inhibitor, induced strong up-regulation of antigen-presenting molecule MHC-II combined with down-regulation of multiple co-stimulation signals, including OX40L, CD70, CD80, CD40 and CD44 (Figure 1).
- Contrary to expectations, NPE1 from commercial suppliers induced strong down-regulation of all DC activation markers except for CD40 (Figure 1). Compounds with this activity profile may be useful for inducing broad suppression of immune responses
- In addition to these prototypical hit compounds, other known immunomodulatory compounds have been tested and showed a variety of activity patterns. Examples include Resveratrol (Figure 1).
Fig. 1. Prototypical results showing different types of activity profiles of dendritic cells.
The assay has a better hit rate compared to other DC assays. Positive hits are expected to show immunomodulatory activity in vivo.
The assay is a screening tool for different types of therapeutics. A variety of DC activity profiles can be detected including the following:
- Hit compounds with immunostimulant activity profile may have therapeutic potential as vaccine adjuvants or for cancer immunotherapy.
- Compounds with co-stimulation inhibitor activity profile may be useful for treating auto-immune conditions.
- Compounds with immunosuppressor activity profile may be useful for inducing broad suppression of immune responses within a narrow time window, such as during organ transplantation.
Ò»±¾µÀ is offering compound screening and hit validation on a fee for service basis, and is open to opportunities for collaborative research, co-development and out-licensing.
Seeking:
- Licensing
- Commercial partner
- Development partner
- Copyright
- Know-how based
- Patent application submitted
- Prof Denise Doolan